Tissue regeneration

Details Tissue regeneration Tissue regeneration

2004-12-17

2010-12-21

Sheikh, Humera N (Department: 1615)

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Particulate form

C604S027000, C604S028000

Reexamination Certificate

active

07854944

ABSTRACT:
A method including positioning a delivery device at a location in a vessel within a mammalian body, introducing a first treatment agent including a cellular component through the delivery device, and introducing a different second treatment agent disposed in a carrier through the delivery device. A method including identifying an infarct region within myocardial tissue and a border region of perfused tissue adjacent the infarct region, introducing a treatment agent including a cellular component to the border region, and introducing a plurality of microparticles to the infarct region. A kit including a treatment agent including a cellular component in a form suitable for percutaneous delivery, and a separate amount of a plurality of microparticles in a form suitable for percutaneous delivery.

REFERENCES:
patent: 4794931 (1989-01-01), Yock
patent: 5000185 (1991-03-01), Yock
patent: 5024234 (1991-06-01), Leary et al.
patent: 5049130 (1991-09-01), Powell
patent: 5100185 (1992-03-01), Menke et al.
patent: 5171217 (1992-12-01), March et al.
patent: 5202745 (1993-04-01), Sorin et al.
patent: 5203338 (1993-04-01), Jang
patent: 5291267 (1994-03-01), Sorin et al.
patent: 5321501 (1994-06-01), Swanson et al.
patent: 5365325 (1994-11-01), Kumasaka et al.
patent: 5372138 (1994-12-01), Crowley et al.
patent: 5459570 (1995-10-01), Swanson et al.
patent: 5464395 (1995-11-01), Faxon et al.
patent: 5465147 (1995-11-01), Swanson
patent: 5485486 (1996-01-01), Gilhousen et al.
patent: 5499630 (1996-03-01), Hiki et al.
patent: 5546948 (1996-08-01), Hamm et al.
patent: 5580856 (1996-12-01), Prestrelski et al.
patent: 5588432 (1996-12-01), Crowley
patent: 5693029 (1997-12-01), Leonhardt
patent: 5722403 (1998-03-01), McGee et al.
patent: 5740808 (1998-04-01), Panescu et al.
patent: 5827313 (1998-10-01), Ream et al.
patent: 5843156 (1998-12-01), Slepian et al.
patent: 5874500 (1999-02-01), Rhee et al.
patent: 5879713 (1999-03-01), Roth et al.
patent: 5900433 (1999-05-01), Igo et al.
patent: 5941868 (1999-08-01), Kaplan et al.
patent: 5957941 (1999-09-01), Ream
patent: 5968064 (1999-10-01), Selmon
patent: 5981568 (1999-11-01), Kunz et al.
patent: 6045565 (2000-04-01), Ellis et al.
patent: 6051648 (2000-04-01), Rhee et al.
patent: 6056744 (2000-05-01), Edwards
patent: 6099864 (2000-08-01), Morrison et al.
patent: 6102904 (2000-08-01), Vigil et al.
patent: 6120520 (2000-09-01), Saadat et al.
patent: 6133231 (2000-10-01), Ferrara et al.
patent: 6134003 (2000-10-01), Tearney et al.
patent: 6159443 (2000-12-01), Hallahan et al.
patent: 6175669 (2001-01-01), Colston et al.
patent: 6177407 (2001-01-01), Rodgers et al.
patent: 6179809 (2001-01-01), Khairkhahan et al.
patent: 6183432 (2001-02-01), Milo
patent: 6187330 (2001-02-01), Wang et al.
patent: 6190353 (2001-02-01), Makower et al.
patent: 6191144 (2001-02-01), Isner
patent: 6193763 (2001-02-01), Mackin
patent: 6197324 (2001-03-01), Crittenden
patent: 6201608 (2001-03-01), Mandella et al.
patent: 6207180 (2001-03-01), Ottoboni et al.
patent: 6210392 (2001-04-01), Vigil et al.
patent: 6217527 (2001-04-01), Selmon et al.
patent: 6217554 (2001-04-01), Green
patent: 6221049 (2001-04-01), Selmon et al.
patent: 6231546 (2001-05-01), Milo et al.
patent: 6235000 (2001-05-01), Milo et al.
patent: 6290729 (2001-09-01), Slepian et al.
patent: 6296602 (2001-10-01), Headley
patent: 6312725 (2001-11-01), Wallace et al.
patent: 6323278 (2001-11-01), Rhee et al.
patent: 6328229 (2001-12-01), Duronio et al.
patent: 6494862 (2002-12-01), Ray et al.
patent: 6554801 (2003-04-01), Steward et al.
patent: 6624245 (2003-09-01), Wallace et al.
patent: 6692466 (2004-02-01), Chow et al.
patent: 2003/0040712 (2003-02-01), Ray et al.
patent: 2004/0181206 (2004-09-01), Chiu et al.
patent: 2005/0015048 (2005-01-01), Chiu et al.
patent: 2005/0070844 (2005-03-01), Chow et al.
patent: 2005/0281883 (2005-12-01), Daniloff et al.
patent: 2194144 (1988-03-01), None
patent: WO-0124775 (2001-04-01), None
patent: WO 0149357 (2001-07-01), None
patent: WO 02/40070 (2002-05-01), None
patent: WO 02/087623 (2002-11-01), None
patent: 03/064637 (2003-08-01), None
patent: WO 03/064637 (2003-08-01), None
patent: WO 03064637 (2003-08-01), None
patent: WO 2004/050013 (2004-06-01), None
patent: WO 2004/091592 (2004-10-01), None
“Vessel”. Stedman's Medical Dictionary 27th Edition. Accessed online on Nov. 7, 2007 at http://www.thomsonhc.com.
PCT/US2005/045627, filed Dec. 16, 2005, “International Search Report and Written Opinion of the International Search Authority,” dated Oct. 13, 2006.
Kawai, K, et al., “Accelerated tissue regeneration through incorporation of basic fibroblast growth factor-impregnated gelatin microspheres into artificial dermis,” Biomaterials, Mar. 2000, 21(5):489-99.
Rowley, JA, et al., “Alginate hydrogels as synthetic extracellular matrix materials,” Biomaterials, Jan. 1999, 20(1):45-53.
Haugland, RP, “Membrane-Permeant Reactive Tracers,” In: Gregory J, ed. Handbook of Fluorescent Probes and Research Products. Eugene: Molecular Probes, Inc., 2002:458-553.
Haugland, RP, “Dialkylcarbocyanine and Dialkylaminostyryl Probes,” In: Gregory J, ed. Handbook of Fluorescent Probes and Research Products. Eugene: Molecular Probes, Inc., 2002:530-534.
Nose, A, et al., “A Novel Cadherin Cell Adhesion Molecule: Its Expression Patterns Associated with Implantation and Organogenesis of Mouse Embryos,” Journal of Cell Biology, vol. 103 (No. 6, Pt. 2), Dec. 1986, 2649-2658.
Chandy, et al., “The development of porous alginate/elastin/PEG composite matrix for cardiovascular engineering”, Journal of Biomaterials Applications, vol. 17, Apr. 2003, pp. 287-301.
Dinbergs, et al., “Cellular response to transforming growth factor-β1 and basic fibroblast growth factor depends on release kinetics and extracellular matrix interactions”, The Journal of Biological Chemistry, vol. 271, No. 47, Nov. 1996, pp. 29822-29829.
Edelman, et al., “Controlled and modulated release of basic fibroblast growth factor”, Biomaterials, vol. 12, Sep. 1999, pp. 619-626.
Johnson, et al., “The stabilization and encapsulation of human growth hormone nto biodegradable microspheres”, Pharmaceutical Research, vol. 14, No. 6, 1997, pp. 730-735.
Shin, et al., “In vivo bone and soft tissue response to injectable, biodegradable oligo(poly(ethylene glycol) fumarate) hydrogels”, Biomaterials 24, Elseview Science Ltd., 2003, pp. 3201-3211.

Affiliated with

Also associated with

Rating

Tissue regeneration does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Tissue regeneration, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tissue regeneration will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4151116